Nuclear Medicine: Page 361

SPECT/CT helps clarify ambiguous bone foci

By Jonathan S. Batchelor

Bone scintigraphy with SPECT has a good track record for detecting metastatic areas with a high lesion-to-background contrast. But a drawback of SPECT has been that anatomic details can be lacking. Researchers from Germany, however, have found that SPECT/CT can increase specificity in cases when SPECT alone is equivocal.

February 8, 2006

IsoRay adds medical advisor

Medical isotope developer IsoRay Medical has appointed Dr. Steven Kurtzman as medical advisor.

January 31, 2006

GE launches Ventri cardiac gamma camera

By AuntMinnie.com staff writers

Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., is launching a new dual-head gamma camera targeted at the nuclear cardiology market.

January 31, 2006

Scintigraphy shows breast cancer response to hormone therapy sooner

By Shalmali Pal

Only a third of breast cancer patients who have endocrine therapy respond to treatment, and the current tests for patient selection are less than optimal. Some imaging techniques may not show results for several months post-treatment. Scintigraphy could be a better, noninvasive way to predict treatment response, according to European researchers.

January 25, 2006

CardiArc receives FDA nod for SPECT unit

By AuntMinnie.com staff writers

Cardiac imaging device developer CardiArc has received Food and Drug Administration 510(k) clearance for its cardiac SPECT gamma camera.

January 24, 2006

MRI, PET/CT show different strengths in tumor staging

By Jonathan S. Batchelor

Whole-body MRI and PET/CT differ in their capabilities when conducting tumor, node, and metastasis (TNM) staging, with PET/CT demonstrating superior sensitivity and specificity for lymph node staging, while whole-body MRI showed strength in detecting distant metastases, according to German researchers.

January 19, 2006